Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Appli...( TARRYTOWN N.Y. Oct. 24 /- Emisphe...)
| HOME >> BIOLOGY >> TECHNOLOGY |
TARRYTOWN, N.Y., Oct. 24 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS) today announced that Gary Riley has been appointed to the position of Vice President, Nonclinical Development and Applied Biology, effective November 6, 2007. Dr. Riley will be responsible for the oversight and management of nonclinical drug efficacy and safety programs, including regulatory toxicology, and the strategic design of discovery projects. Dr. Riley will report directly to Michael V. Novinski, President and Chief Executive Officer. Emisphere Technologies, Inc. is a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules and pharmaceutical compounds using its eligen(R) technology.
"Gary Riley has great hands-on experience in managing all aspects of nonclinical drug development and in bringing issues before the FDA and European Regulatory Agencies," said Michael V. Novinski, President and Chief Executive Officer of Emisphere Technologies, Inc. "Dr. Riley also brings a real expertise in integrating knowledge of the biological response to novel drug delivery technologies and accelerating the product cycle. It is a wealth of experience that we are excited to bring to Emisphere."
Dr. Riley has over 18 years experience as a nonclinical scientist and
manager in the biotechnology and pharmaceutical industries. He was the Vice
President of Toxicology and Applied Biology at Alkermes, Inc. in Cambridge,
Massachusetts, where he directed the design, execution and interpretation
of toxicology and nonclinical efficacy programs for a wide range of
parenteral drug delivery formulations. Dr. Riley played a key role in
obtaining FDA approvals for three novel controlled release for
'/>"/>
| SOURCE Emisphere Technologies, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. Sharon Ethanol appoints operations director
2. Kyron appoints former AMA chairman to board
3. Brady appoints GE efficiency expert as CTO
4. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
5. Johnson Controls appoints Roell to head EOC
6. SecurePipe appoints two senior execs
7. Milwaukees PointOne appoints new president and CEO
8. Third Wave appoints new chairman
9. Midwest Venture Summit disappoints; Cato grades Midwest governors
10. Sonic Foundry appoints Engineering Dean and Cometa CEO to Board of Directors
11. TeraMEDICA Appoints Prekop as New President
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |